---

Related Articles:

P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

2012-10-01

[J. Pharmacol. Exp. Ther. 343(1) , 53-61, (2012)]

Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.

2011-04-20

[Bioconjug. Chem. 22(4) , 752-8, (2011)]

Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.

2011-10-01

[Ther. Drug Monit. 33(5) , 619-26, (2011)]

Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.

2010-01-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(1) , 13-20, (2010)]

An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation.

2010-05-01

[Int. J. Legal Med. 124(3) , 187-94, (2010)]